News | Implantable Cardioverter Defibrillator (ICD) | February 03, 2016

Biotronik Announces CE Approval for MRI AutoDetect ICDs and CRT-Ds

Ilivia devices capable of automatically adapting to an MRI environment

Biotronik, CE approval, Ilivia ICDs and CRT-Ds, ProMRI, MRI AutoDetect

February 3, 2016 — Biotronik announced CE approval for its new Ilivia implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy devices (CRT-Ds), improving magnetic resonance imaging (MRI) access for cardiac device patients. Ilivia devices come with the company’s ProMRI technology, as well as MRI AutoDetect.

At present, when a cardiac device patient undergoes an MRI scan, a cardiologist must program his or her device into a special mode that temporarily reduces the device’s functionality until the MRI scan is completed. Following the scan, the cardiologist must switch off the device’s MRI mode to allow the patient to once again have the full therapeutic benefits of their implanted device.

MRI AutoDetect allows the cardiologist to activate a special window, lasting up to 14 days, in which all device functionality is maintained until the patient is undergoing the scan itself. At that point, the device switches into MRI mode automatically. Once the scan is completed, all device functionality is restored, again automatically and without the need for the cardiologist’s intervention. Soon after the scan, the cardiologist receives a full report via transmission through Biotronik Home Monitoring.

“It is only in the last few years that cardiac device patients could safely undergo MRI scans at all. However, even now, patients aren’t fully protected if they have an event while their devices are programmed in MRI mode — a period that currently can last a day or more depending on hospital workflows,” commented Richard Kobza, M.D., head of cardiology, Luzerner Kantonsspital, Lucerne, Switzerland. “Reducing the amount of time a device is in MRI mode is particularly crucial for ICD and CRT-D patients, and with MRI AutoDetect the only time these patients won’t be able to benefit from full device therapy is the short 30-minute window they spend in the MRI machine itself.”

Ilivia devices also feature MultiPole Pacing (MPP) to further improve therapy for CRT patients, the company’s Closed Loop Stimulation (CLS) algorithm for more adaptive pacing, and DX technology for ICDs and CRT-Ds.

For more information: www.biotronik.com


Related Content

News | Cardiac Resynchronization Therapy Devices (CRT)

October 27, 2021 ​​— EBR Systems Inc., developer of the world’s first wireless cardiac pacing system for heart failure ...

Home October 27, 2021
Home
News | Cardiac Resynchronization Therapy Devices (CRT)

August 3, 2021 — In association with Heart Rhythm 2021, Biotronik announced first enrollments in the landmark BIO ...

Home August 03, 2021
Home
News | Cardiac Resynchronization Therapy Devices (CRT)

March 3, 2021 — Medtronic announced new results from the landmark REVERSE trial, evaluating outcomes of cardiac ...

Home March 03, 2021
Home
News | Cardiac Resynchronization Therapy Devices (CRT)

May 13, 2020 — Cardiac resynchronization therapy (CRT) using biventricular pacing (BVP) or His bundle pacing (HBP) is ...

Home May 13, 2020
Home
Feature | Cardiac Resynchronization Therapy Devices (CRT) | Valentina Kutyifa M.D., Ph.D.

Cardiovascular disease is the leading cause of death for women in North America, and women with heart failure often ...

Home March 09, 2020
Home
News | Cardiac Resynchronization Therapy Devices (CRT) | Dave Fornell, Editor

May 15, 2019 — A pilot trial has shown His pacing in cardiac resynchronization therapy (CRT) has been shown to ...

Home May 15, 2019
Home
News | Cardiac Resynchronization Therapy Devices (CRT)

April 29, 2019 — Biotronik announced the full commercial launch of the Acticor device family, including Acticor DX and ...

Home April 29, 2019
Home
News | Cardiac Resynchronization Therapy Devices (CRT)

April 18, 2019 – Biotronik announced the European market release of what it calls the world’s smallest implantable ...

Home April 18, 2019
Home
Technology | Cardiac Resynchronization Therapy Devices (CRT)

March 15, 2019 – Biotronik announced U.S. Food and Drug Administration (FDA) approval of the Acticor and Rivacor high ...

Home March 15, 2019
Home
News | Cardiac Resynchronization Therapy Devices (CRT)

May 22, 2018 — Medtronic plc announced study results showing its AdaptivCRT algorithm is associated with improved ...

Home May 22, 2018
Home
Subscribe Now